company background image
MEDI

Medicon Hellas ATSE:MEDIC Stock Report

Last Price

€3.16

Market Cap

€14.0m

7D

0.3%

1Y

29.5%

Updated

09 Aug, 2022

Data

Company Financials
MEDIC fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance6/6
Financial Health6/6
Dividends0/6

MEDIC Stock Overview

Medicon Hellas S.A. operates in the diagnostics industry.

Medicon Hellas Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Medicon Hellas
Historical stock prices
Current Share Price€3.16
52 Week High€5.40
52 Week Low€2.22
Beta0.97
1 Month Change14.08%
3 Month Change-11.49%
1 Year Change29.51%
3 Year Change68.09%
5 Year Change530.74%
Change since IPO-59.58%

Recent News & Updates

Jun 10
Medicon Hellas (ATH:MEDIC) May Have Issues Allocating Its Capital

Medicon Hellas (ATH:MEDIC) May Have Issues Allocating Its Capital

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Amongst...

Apr 30
Estimating The Intrinsic Value Of Medicon Hellas S.A. (ATH:MEDIC)

Estimating The Intrinsic Value Of Medicon Hellas S.A. (ATH:MEDIC)

In this article we are going to estimate the intrinsic value of Medicon Hellas S.A. ( ATH:MEDIC ) by taking the...

Shareholder Returns

MEDICGR Medical EquipmentGR Market
7D0.3%-0.5%-1.2%
1Y29.5%-23.6%-1.1%

Return vs Industry: MEDIC exceeded the Greek Medical Equipment industry which returned -22.6% over the past year.

Return vs Market: MEDIC exceeded the Greek Market which returned -0.5% over the past year.

Price Volatility

Is MEDIC's price volatile compared to industry and market?
MEDIC volatility
MEDIC Average Weekly Movement10.5%
Medical Equipment Industry Average Movement7.0%
Market Average Movement4.8%
10% most volatile stocks in GR Market7.2%
10% least volatile stocks in GR Market2.9%

Stable Share Price: MEDIC is more volatile than 90% of Greek stocks over the past 3 months, typically moving +/- 11% a week.

Volatility Over Time: MEDIC's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of Greek stocks.

About the Company

FoundedEmployeesCEOWebsite
1988169Maria Dimotsantou Sotiriouhttps://www.mediconsa.com

Medicon Hellas S.A. operates in the diagnostics industry. The company offers instruments, tests, and procedures for public and private hospitals, primary care centers, diagnostic centers, and private laboratories in Greece and internationally. The company imports and distributes analytical workstations for chemistry, immunochemistry and hematology labs, intensive care units, and point-of-care systems under the MLR name.

Medicon Hellas Fundamentals Summary

How do Medicon Hellas's earnings and revenue compare to its market cap?
MEDIC fundamental statistics
Market Cap€13.97m
Earnings (TTM)€3.04m
Revenue (TTM)€21.51m

4.6x

P/E Ratio

0.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
MEDIC income statement (TTM)
Revenue€21.51m
Cost of Revenue€5.82m
Gross Profit€15.69m
Other Expenses€12.65m
Earnings€3.04m

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)0.69
Gross Margin72.94%
Net Profit Margin14.14%
Debt/Equity Ratio75.9%

How did MEDIC perform over the long term?

See historical performance and comparison
We’ve recently updated our valuation analysis.

Valuation

Is MEDIC undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for MEDIC?

Other financial metrics that can be useful for relative valuation.

MEDIC key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue0.8x
Enterprise Value/EBITDA2.7x
PEG Ration/a

Price to Earnings Ratio vs Peers

How does MEDIC's PE Ratio compare to its peers?

MEDIC PE Ratio vs Peers
The above table shows the PE ratio for MEDIC vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average26.4x
VIDAVO Vidavo
57.3xn/a€3.4m
ALEMG Euromedis Groupe
7.4x17.6%€16.7m
RAYT Rayont
38.4xn/aUS$14.4m
VASO Vaso
2.5xn/aUS$16.3m
MEDIC Medicon Hellas
4.6xn/a€14.0m

Price-To-Earnings vs Peers: MEDIC is good value based on its Price-To-Earnings Ratio (4.6x) compared to the peer average (26.4x).


Price to Earnings Ratio vs Industry

How does MEDIC's PE Ratio compare vs other companies in the European Medical Equipment Industry?

Price-To-Earnings vs Industry: MEDIC is good value based on its Price-To-Earnings Ratio (4.6x) compared to the European Medical Equipment industry average (28.2x)


Price to Earnings Ratio vs Fair Ratio

What is MEDIC's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

MEDIC PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio4.6x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate MEDIC's Price-To-Earnings Fair Ratio for valuation analysis.


Share Price vs Fair Value

What is the Fair Price of MEDIC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: MEDIC (€3.16) is trading below our estimate of fair value (€16.36)

Significantly Below Fair Value: MEDIC is trading below fair value by more than 20%.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies

Future Growth

How is Medicon Hellas forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


16.0%

Forecasted Healthcare industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Medicon Hellas has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Discover growth companies

  • Examine whether Medicon Hellas is trading at an attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.
  • Medicon Hellas competitive advantages and company strategy can generally be found in its financial reports archived here.

Past Performance

How has Medicon Hellas performed over the past 5 years?

Past Performance Score

6/6

Past Performance Score 6/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


4.2%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: MEDIC has high quality earnings.

Growing Profit Margin: MEDIC's current net profit margins (14.1%) are higher than last year (5%).


Past Earnings Growth Analysis

Earnings Trend: MEDIC's earnings have grown by 4.2% per year over the past 5 years.

Accelerating Growth: MEDIC's earnings growth over the past year (301.8%) exceeds its 5-year average (4.2% per year).

Earnings vs Industry: MEDIC earnings growth over the past year (301.8%) exceeded the Medical Equipment industry 23.1%.


Return on Equity

High ROE: MEDIC's Return on Equity (21.7%) is considered high.


Discover strong past performing companies

Financial Health

How is Medicon Hellas's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: MEDIC's short term assets (€21.1M) exceed its short term liabilities (€4.7M).

Long Term Liabilities: MEDIC's short term assets (€21.1M) exceed its long term liabilities (€11.5M).


Debt to Equity History and Analysis

Debt Level: MEDIC's net debt to equity ratio (6.5%) is considered satisfactory.

Reducing Debt: MEDIC's debt to equity ratio has reduced from 350% to 75.9% over the past 5 years.

Debt Coverage: MEDIC's debt is well covered by operating cash flow (42.3%).

Interest Coverage: MEDIC's interest payments on its debt are well covered by EBIT (34x coverage).


Balance Sheet


Discover healthy companies

Dividend

What is Medicon Hellas's current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate MEDIC's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate MEDIC's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if MEDIC's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if MEDIC's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: MEDIC is not paying a notable dividend for the Greek market.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as MEDIC has not reported any payouts.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

8.4yrs

Average board tenure


CEO

Maria Dimotsantou Sotiriou (69 yo)

no data

Tenure

Ms. Maria Dimotsantou Sotiriou has been the Chairman of the Board and Chief Executive Officer of Medicon Hellas S.A. since October 31, 2014. Ms. Dimotsantou Sotiriou speaks English.


Board Members

Experienced Board: MEDIC's board of directors are considered experienced (8.4 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Medicon Hellas S.A.'s employee growth, exchange listings and data sources


Key Information

  • Name: Medicon Hellas S.A.
  • Ticker: MEDIC
  • Exchange: ATSE
  • Founded: 1988
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Implied Market Cap: €13.966m
  • Shares outstanding: 4.42m
  • Website: https://www.mediconsa.com

Number of Employees


Location

  • Medicon Hellas S.A.
  • Melitona 5-7
  • Gerakas
  • 153 44
  • Greece

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/08/09 00:00
End of Day Share Price2022/08/09 00:00
Earnings2021/12/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.